Atladottir HO, Gyllenberg D, Langridge A, Sandin S, Hansen SN, Leonard H, Gissler M, Reichenberg A, Schendel DE, Bourke J, Hultman CM, Grice DE, Buxbaum JD, Parner ET (2015). The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison. European Child and Adolescent Psychiatry
Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, Mrazek DA, Jacobsen SJ (2002). How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Archives of Pediatrics and Adolescent Medicine
Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ (2007). Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. Journal of Developmental and Behavioral Pediatrics
Bruchmuller K, Margraf J, Schneider S (2012). Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. Journal of Consulting and Clinical Psychology
Chan E, Fogler JM, Hammerness PG (2016). Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review. JAMA
Chen CY, Yeh HH, Chen KH, Chang IS, Wu EC, Lin KM (2011). Differential effects of predictors on methylphenidateinitiation and discontinuation among young people with newly diagnosed attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology
Cherkasova M, Sulla EM, Dalena KL, Ponde MP, Hechtman L (2013). Developmental course of attention deficit hyperactivity disorder and its predictors. Journal of the Canadian Academy of Child and Adolescent Psychiatry
Chien IC, Lin CH, Chou YJ, Chou P (2012). Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996–2005: a national population-based study. Social Psychiatry and Psychiatric Epidemiology
Coon ER, Quinonez RA, Moyer VA, Schroeder AR (2014). Overdiagnosis: how our compulsion for diagnosis may be harming children. Pediatrics
Dalsgaard S, Nielsen HS, Simonsen M (2013). Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study. Journal of Child and Adolescent Psychopharmacology
Directorate-General of Budget Accounting and Statistics, Executive Yuan, Taiwan (2015). Resident Population by 5-Year, 10-Year Age Group.
Evans SW, Owens JS, Bunford N (2014). Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Journal of Clinical Child and Adolescent Psychology
Feldman HM, Reiff MI (2014). Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents. New England Journal of Medicine
Findling RL (2008). Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Clinical Therapeutics
Garbe E, Mikolajczyk RT, Banaschewski T, Petermann U, Petermann F, Kraut AA, Langner I (2012). Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study. Journal of Child and Adolescent Psychopharmacology
Garfield CF, Dorsey ER, Zhu S, Huskamp HA, Conti R, Dusetzina SB, Higashi A, Perrin JM, Kornfield R, Alexander GC (2012). Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000–2010. Academic Pediatrics
Gau SS, Chong MY, Chen TH, Cheng AT (2005). A 3-year panel study of mental disorders among adolescents in Taiwan. American Journal of Psychiatry
Getahun D, Jacobsen SJ, Fassett MJ, Chen W, Demissie K, Rhoads GG (2013). Recent trends in childhood attention-deficit/hyperactivity disorder. JAMA Pediatrics
Hodgkins P, Sasane R, Meijer WM (2011). Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clinical Therapeutics
Holden SE, Jenkins-Jones S, Poole CD, Morgan CL, Coghill D, Currie CJ (2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child and Adolescent Psychiatry and Mental Health
Hong M, Kwack YS, Joung YS, Lee SI, Kim B, Sohn SH, Chung US, Yang J, Bhang SY, Hwang JW, Choi HY, Oh IH, Lee YJ, Bahn GH (2014). Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008–2011. Asia-Pacific Psychiatry
Huang CL, Chu CC, Cheng TJ, Weng SF (2014). Epidemiology of treated attention-deficit/hyperactivity disorder (ADHD) across the lifespan in Taiwan: a nationwide population-based longitudinal study. PLoS ONE
LeFever GB, Dawson KV, Morrow AL (1999). The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. American Journal of Public Health
Liang KY, Zeger SL (1986). Longitudinal data analysis using generalized linear models. Biometrika
Lien YT, Yeh HH, Soong WT, Jeng SF, Huang N, Chen CY (2015). Factors associated with treatment mode and termination among preschoolers with ADHD in Taiwan. Psychiatric Services
McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC (2012). The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatrics
Mohr Jensen C, Steinhausen HC (2015). Time trends in incidence rates of diagnosed attention-deficit/hyperactivity disorder across 16 years in a nationwide Danish registry study. Journal of Clinical Psychiatry
Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, Dormuth CR (2012). Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ
Nussbaum NL (2012). ADHD and female specific concerns: a review of the literature and clinical implications. Journal of Attention Disorders
Oner O, Yilmaz ES, Karada XFH, Vural M, Vural EH, Akbulat A, Gursoz HX, Turkcapar H, Kerman S (2014). ADHD Medication Trends in Turkey: 2009–2013. Journal of Attention Disorders. doi:10.1177/1087054714523129.
Partridge B, Lucke J, Hall W (2012). Public attitudes towards the acceptability of using drugs to treat depression and ADHD. Australian and New Zealand Journal of Psychiatry
Partridge B, Lucke J, Hall W (2014). Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD. BMC Psychiatry
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry
Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA (2014). ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. International Journal of Epidemiology
Ponizovsky AM, Marom E, Fitoussi I (2014). Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005–2012. Pharmacoepidemiology and Drug Safety
Rapoport JL (2013). Pediatric psychopharmacology: too much or too little?
Rowland AS, Umbach DM, Stallone L, Naftel AJ, Bohlig EM, Sandler DP (2002). Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. American Journal of Public Health
Rucklidge JJ (2010). Gender differences in attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America
Safer DJ (2000). Are stimulants overprescribed for youths with ADHD?
Annals of Clinical Psychiatry
Safer DJ (2015). Is ADHD really increasing in youth?
Journal of Attention Disorders. doi: 10.1177/1087054715586571.
Safer DJ, Zito JM, Fine EM (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics
Sciutto MJ, Eisenberg M (2007). Evaluating the evidence for and against the overdiagnosis of ADHD. Journal of Attention Disorders
Stuhec M, Locatelli I, Svab V (2015). Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective. Journal of Child and Adolescent Psychopharmacology
Thapar A, Cooper M (2016). Attention deficit hyperactivity disorder. Lancet
Thomas R, Sanders S, Doust J, Beller E, Glasziou P (2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics
Treceno C, Martin Arias LH, Sainz M, Salado I, Garcia Ortega P, Velasco V, Jimeno N, Escudero A, Velasco A, Carvajal A (2012). Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y Leon (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate. Pharmacoepidemiology and Drug Safety
Vaughan BS, March JS, Kratochvil CJ (2012). The evidence-based pharmacological treatment of paediatric ADHD. International Journal of Neuropsychopharmacology
Visser SN, Lesesne CA, Perou R (2007). National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics
119 (Suppl. 1), S99–S106.
Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, Perou R, Blumberg SJ (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry
53, 34–46 e32.
Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A (2008). Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Annals of Pharmacotherapy
Wu CS, Lai MS, Gau SS, Wang SC, Tsai HJ (2014). Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS ONE